Mansour Diana, Inki Pirjo, Gemzell-Danielsson Kristina
New Croft Centre, Newcastle upon Tyne, UK.
Eur J Contracept Reprod Health Care. 2010 Feb;15(1):4-16. doi: 10.3109/13625180903427675.
To provide a comprehensive and objective summary of contraceptive failure rates for a variety of methods based on a systematic review of the literature.
Medline and Embase were searched using the Ovid interface from January 1990 to February 2008, as well as the reference lists of published articles, to identify studies reporting contraceptive efficacy as a Pearl Index or life-table estimate. Reports that recruited less than 400 subjects per study group and those covering less than six cycles/six months were excluded. In addition, unlicensed products or those not internationally available, emergency contraception, and vasectomy studies were excluded.
Information was identified and extracted from 139 studies. One-year Pearl Indices reported for short-acting user-dependent hormonal methods were generally less than 2.5. Gross life-table rates for long-acting hormonal methods (implants and the levonorgestrel releasing-intrauterine system [LNG-IUS]) generally ranged between 0-0.6 per 100 at one year, but wider ranges (0.1-1.5 per 100) were observed for the copper intrauterine devices (0.1-1.4 per 100 for Cu-IUDs with surface area > or =300 mm( 2 ) and 0.6-1.5 per 100 for those with surface area <300 mm( 2 )). Barrier and natural methods were the least effective.
Our review broadly confirms the hierarchy of contraceptive effectiveness in descending order as: (1) female sterilisation, long-acting hormonal contraceptives (LNG-IUS and implants); (2) Cu-IUDs with > or =300 mm( 2 ) surface area; (3) Cu-IUDs with <300 mm( 2 ) surface area and short-acting hormonal contraceptives (injectables, oral contraceptives, the patch and vaginal ring), and (4) barrier methods and natural methods.
基于对文献的系统评价,全面、客观地总结各种避孕方法的失败率。
使用Ovid界面检索1990年1月至2008年2月期间的Medline和Embase数据库,以及已发表文章的参考文献列表,以识别将避孕效果报告为Pearl指数或生命表估计值的研究。每个研究组招募少于400名受试者的报告以及涵盖少于六个周期/六个月的报告被排除。此外,未获许可的产品或国际上不可用的产品、紧急避孕和输精管结扎术研究也被排除。
从139项研究中识别并提取了信息。短效依赖使用者的激素方法报告的一年Pearl指数通常小于2.5。长效激素方法(植入剂和左炔诺孕酮宫内缓释系统[LNG-IUS])的总生命表率在一年时通常在每100人0-0.6之间,但铜宫内节育器的范围更广(表面积≥300 mm(2)的Cu-IUD为每100人0.1-1.4,表面积<300 mm(2)的为每100人0.6-1.5)。屏障法和自然避孕法效果最差。
我们的综述大致证实了避孕效果从高到低的排序如下:(1)女性绝育、长效激素避孕药(LNG-IUS和植入剂);(2)表面积≥300 mm(2)的铜宫内节育器;(3)表面积<300 mm(2)的铜宫内节育器和短效激素避孕药(注射剂、口服避孕药、贴片和阴道环),以及(4)屏障法和自然避孕法。